Androgen receptors containing expanded polyglutamine tracts exhibit progressive toxicity when stably expressed in the

D M Avila1, D R Allman, J-M Gallo

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.

Insights

X-linked spinal and bulbar muscular atrophy (SBMA) is linked to expanded repeat androgen receptors (Exp-ARs). A cell model shows Exp-ARs cause neuronal toxicity through mechanisms independent of intracellular aggregates.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • X-linked spinal and bulbar muscular atrophy (SBMA) pathogenesis involves expanded glutamine repeats in the androgen receptor (AR).
  • Understanding the toxicity mechanisms of expanded repeat ARs (Exp-ARs) in neurons is crucial for SBMA research.

Purpose of the Study:

  • To establish and characterize a cell culture model for investigating Exp-AR toxicity in neurons.
  • To explore the mechanisms underlying Exp-AR neurotoxicity, particularly in relation to intracellular aggregates.

Main Methods:

  • Stable transfection of SH-SY5Y neuroblastoma cells with normal AR and Exp-AR cDNAs.
  • Cell morphology, growth, hormone binding, and nuclear localization assessments.
  • Long-term propagation of transfected cell lines to observe Exp-AR population dynamics.

Main Results:

  • No initial differences in cell properties or hormone binding between normal AR and Exp-AR expressing cells.
  • Exp-ARs were primarily localized in the nucleus, similar to normal AR.
  • A progressive decline in Exp-AR cell population occurred during propagation, indicating selection against Exp-AR expression, independent of aggregate formation.

Conclusions:

  • Exp-ARs exert toxicity in a neuronal cell model through mechanisms not dependent on intracellular aggregate formation.
  • A selection process actively removes cells expressing physiological levels of Exp-AR.
  • Further research is needed to elucidate the precise non-aggregate-dependent mechanisms of Exp-AR neurotoxicity in SBMA.